Headlines

Go To Pro Hockey Rumors
Go To Hoops Rumors

Newsstand

Luis Robert Jr. Facing Lengthy Absence

By | at

The White Sox placed center fielder Luis Robert Jr. on the 10-day injured list over the weekend, and while the team didn’t provide a timetable for his return, Robert himself told the Sox beat that he’s been diagnosed with a Grade 2 hip flexor strain. Daryl Van Schouwen of the Chicago Sun-Times reports that the Sox are currently anticipating an absence of six to eight weeks for the star outfielder. Some in the organization are more concerned and think Robert could miss three-plus months, USA Today’s Bob Nightengale writes.

Robert exited Friday’s game against the Royals after he injured himself rounding first base on a double into the left field corner (video link). An exact timetable surely depends on how he progresses through the early stages of his rehab process. Robert endured a strain in this same right hip flexor back in 2021 as well, though that was a Grade 3 strain — more severe than his current injury. He wound up missing nearly three and a half months with that injury.

Robert, 26, made his first All-Star team and nabbed some down-ballot MVP votes in 2023 after he hit .264/.315/.542 with 38 home runs and 20 steals in 145 games. He was out to a slower start to the 2024 season, batting .214/.241/.500 with a pair of big flies and an uncharacteristic 38% strikeout rate — albeit in a tiny sample of 39 plate appearances.

The Sox weren’t ever expected to compete this season, but a minimum month-and-a-half absence — and potentially a good bit longer on the shelf — for their best player is a critical blow to a largely torn-down roster. With Robert out for the foreseeable future, the Sox will likely turn to offseason trade acquisition Dominic Fletcher in center. He’s already started two games there since Robert first sustained his injury. Listed at just 5’6″, Fletcher is undersized relative to other big leaguers but nevertheless touted as a plus defender at all three outfield spots. Veterans Andrew Benintendi and Robbie Grossman are lined up for frequent corner work now, although the team surely hopes 25-year-old Oscar Colas can get back on track in Triple-A and reenter the right field mix after a dismal 2023 season.

There was some speculation regarding a potential trade of Robert over the winter, as the Sox are once again in a rebuilding mode — under new front office leadership for the first time in two decades. But general manager Chris Getz never seemed all that likely to trade Robert, who is one of the game’s most dynamic talents and is signed to a club-friendly contract. Robert is being paid $12.5MM this season and $15MM next year. The Sox hold a pair of club options for the 2026 and 2027 seasons, both valued at $20MM with a $2MM buyout. In other words, he’s guaranteed $29.5MM over the next two seasons but could be controlled all the way through 2027 for a total of $67.5MM.

It’s an eminently reasonable price, though the mounting injury history for Robert is certainly a concern. He’s only reached 100 games in a big league season once (last year) and seems unlikely to get there in 2024 following this injury. Critics might argue that his trade value was at his peak this offseason, coming off a season of MVP-caliber production in a career-high 595 plate appearances. It’s overwhelmingly rare to see an established talent with this much team control traded, however, and Getz would’ve been well within his right to hold out for a return that rivals any of the largest trade packages we’ve seen in recent memory.

On the plus side for the Sox, Robert is so talented and still signed for so long that even if he misses multiple months, his trade value ought to remain considerable. And, of course, the team doesn’t need to trade him this summer or even next offseason or at the 2025 trade deadline. Depending on how the team’s current rebuild progresses (or fails to do so), Robert could conceivably still be part of a contending White Sox club in a few years’ time. And if things do stall out longer than the team currently hopes, he’d command a haul even if he were being marketed with “only” two years or one and a half years of club control remaining.

For now, the focus will be squarely on getting Robert back onto the field — though it seems a late-May return is a best-case scenario. Nightengale suggests the Sox will at least be open to the idea of outside acquisitions and lists free agent Tommy Pham as a potential fit.

Braves Place Spencer Strider On Injured List With UCL Sprain

By | at

April 7: The Braves officially placed Strider on the 15-day injured list this morning with a UCL sprain. The club recalled right-hander Allan Winans in the corresponding move. Winans, 28, posted a 5.29 ERA and 4.09 FIP in six starts with Atlanta last year.

April 6: Braves right-hander Spencer Strider underwent an MRI today and the testing revealed that the ace hurler has suffered damage to the ulnar collateral ligament in his right elbow, per a team announcement. The next step for the Braves is for Strider to be evaluated by noted orthopedic surgeon Dr. Keith Meister, though the club noted that a date for that visit has yet to be determined.

UCL damage is often a precursor to Tommy John surgery, though it appears no determination has yet been made regarding Strider’s specific treatment plan. If Strider does end up going under the knife, it won’t be the first time the hurler’s right elbow has required surgery. Before being drafted by the Braves in the fourth round of the 2020 draft, Strider underwent Tommy John surgery back in 2019 while pitching for Clemson University. If required, a second surgery would surely bring Strider’s 2024 campaign to an early close while also shelving him for much of the 2025 campaign as well.

Even less severe options are likely to result in an extended absence for the right-hander, however. For example, Red Sox righty Lucas Giolito underwent an internal brace procedure on his UCL last month that could allow him to pitch the entire 2025 campaign, though he’ll still miss all of the current season. Meanwhile, Guardians right-hander Triston McKenzie required only rehab for a UCL sprain suffered last June and managed to return to the mound after just over three months on the shelf.

Regardless of what treatment is ultimately prescribed for Strider, it appears he’s ticketed for a significant absence. It’s a brutal blow for the Braves, though not entirely unexpected after the club announced yesterday that Strider would undergo an MRI on his elbow. The fourth place finisher in NL Cy Young award voting last year, Strider has emerged as one of the best young pitchers in the sport over the past two seasons, pitching to an excellent 3.36 ERA with a sterling 2.43 FIP while striking out a sensational 37.4% of batters faced. That incredible strikeout rate is by far the best of all qualified starters over the past two seasons, with reigning NL Cy Young award winner Blake Snell, who sports a 31.7% rate, standing as the only other pitcher to post a figure north of 30%.

Fortunately for Atlanta, the club is about as well equipped as any team could be to handle an extended absence from a pitcher of Strider’s caliber. Pending free agent Max Fried is an ace in his own right with a career 3.06 ERA, while veteran southpaw Chris Sale is only a few years removed from being one of the most dominant pitchers on the planet in Chicago and Boston. With those two at the front of the rotation, veterans Charlie Morton and Reynaldo Lopez in the middle, and quality youngsters Bryce Elder and AJ Smith-Shawver available as depth options for the fifth spot in the rotation, the Braves’ rotation should be able to support the club’s excellent offense as they push for their seventh consecutive NL East title even without Strider in the mix.

Stephen Strasburg Officially Retires

By | at

April 7: Strasburg officially announced his retirement in a statement (as relayed by Ghiroli) this morning.

“Today, I am announcing my retirement from the game I love,” the statement reads. “I realized after repeated attempts to return to pitching, injuries no longer allow me to perform at a Major League level… Although I will always wish there were more games to be pitched, I find comfort knowing I left it all out there for the only team I’ve known. My family and I are truly fortunate and blessed to have experienced this baseball journey in the Nation’s Capitol.”

The Nationals also released statements thanking Strasburg from owner Mark Lerner and GM Mike Rizzo.

“No one can dispute the indelible impact he had on our organization,” Lerner said of Strasburg in the statement. “He put us on the map as World Champions and changed the face of our franchise.”

“From his Major League debut in 2010 through leading us to a title as the World Series MVP in 2019, the impact he’s had on our ball club is undeniable. He will go down as one of the best players in Washington Nationals history, and it was my honor to be part of that journey.”

April 6: Right-hander Stephen Strasburg has officially retired, as noted by Andrew Golden of the Washington Post. Neither the Nationals or Strasburg have announced the decision, which was posted on MLB.com’s transactions log this evening. Golden adds that Strasburg will be paid the $105MM left on his seven-year, $345MM deal with the Nationals, though Strasburg has reportedly agreed to defer some of his remaining salary. Golden adds that the specifics of the deferrals are not yet clear, though The Athletic’s Britt Ghiroli makes clear that the arrangement does not lower the total value of Strasburg’s deal with the club.

The news concludes a lengthy saga that saw Strasburg’s initial retirement plans, which came to light in August of last year, scuttled by a dispute between the player and team over the remainder of his contract with the club that reportedly arose when the team sought to change the terms of their initial retirement agreement, which would have seen the right-hander be paid in full. Whether or not Strasburg would retire was largely immaterial from a baseball perspective, as the 35-year-old has been shut down from all baseball activity for nearly a year due to nerve damage and thoracic outlet syndrome, which has interfered with the veteran’s ability to perform basic tasks such as opening doors or lifting his young children in recent years.

Those injuries limited Strasburg to just eight starts over the course of his megadeal with Washington, which came on the heels of the righty winning World Series MVP honors in 2019 for his role in bringing home the only championship in franchise history. Strasburg’s heroics in 2019, which saw him pitch to an excellent 3.32 ERA while leading the NL with 209 innings pitched in the regular season before dominating with a 1.98 ERA in 36 1/3 postseason innings that fall, act as a capstone on an illustrious 13-year career that was cut short by injuries.

When he was selected first overall by the Nationals in the 2009 draft, Strasburg was among the most heralded amateur talents in the history of the sport thanks to his work at San Diego State University, where he pitched to a sterling 1.43 ERA and racked up 328 strikeouts over his final two seasons in college. He ascended through the minor leagues quickly to make his big league debut in June of the 2010 season, allowing two runs in seven innings against Pittsburgh while striking out 14 Pirates and flashing a triple-digit fastball.

Unfortunately, the right-hander’s debut season was cut short by Tommy John surgery, though he did manage to make 12 starts where he pitched to a phenomenal 2.91 ERA with an even better 2.08 FIP. From the moment he returned to the mound at the end of the 2011 season, however, Strasburg joined a core of young talent in Washington that also included the likes of Bryce Harper, Ryan Zimmerman, Gio Gonzalez, and Anthony Rendon. That group led the club to eight consecutive winning seasons from 2012 to 2019 that included five trips to the playoffs, including the aforementioned World Series championship in 2019.

That eight-year stretch saw Strasburg dominate to the tune of a 3.21 ERA and 3.03 FIP in 222 starts at the front of the D.C. rotation while striking out 28.9% of batters faced. Among pitchers with at least 800 innings during that time, Strasburg posted the fourth-best strikeout rate and sixth-best FIP while ranking eleventh in ERA, and 30th in both walk rate and groundball rate. Strasburg’s time at the top of the Nationals rotation culminated in 2019, when he led the Nationals through the playoffs against the Brewers, Dodgers, and Cardinals alongside Max Scherzer and Patrick Corbin before the club felled the Astros in seven games to secure the Commissioner’s Trophy.

Following the win, Strasburg opted out of the remainder of his seven-year $175MM deal with Washington in order to test the open market for the first time in his career. The club went over the top to keep their franchise face, signing the then-31-year-old Strasburg to a deal that would take him through his age-37 season. That contract will go down as one of the worst in MLB history, as Strasburg pitched just 31 1/3 innings of 6.98 ERA baseball after it took effect in 2020, while the Nationals found themselves plunged into a lengthy rebuild by the summer of 2021.

While injuries may have derailed Strasburg’s career in his final years, few players ever reach the peaks that the three-time All Star did during his time in the majors. The right-hander enters the record books with a career 3.24 ERA (127 ERA+) and 3.02 FIP in 1,470 innings of work. He struck out 1,723 batters in his career while going 113-62 in 247 career starts in the regular season. He pairs those fantastic career numbers with even better postseason figures, including a 1.46 ERA in 55 1/3 playoff innings and a whopping 32.6% strikeout rate during the postseason. MLB Trade Rumors congratulates Strasburg on a phenomenal career and wishes him the best as he officially enters retirement.

Shane Bieber To Undergo Tommy John Surgery

By | at

Guardians ace Shane Bieber will soon be undergoing a Tommy John surgery after experiencing elbow pain in each of his last two starts, the team announced.  Bieber will miss the rest of the 2024 season and roughly half of the 2025 season, as per the usual recovery timeline for TJ procedures.  As initially reported by MLB.com’s Mandy Bell, right-hander Peter Strzelecki has been called to take Bieber’s roster spot, now that the Guards have officially placed Bieber on the 15-day injured list.  (He’ll inevitably be moved to the 60-day IL when Cleveland next needs to open a 40-man roster spot.)

The devastating news comes on the heels of an injury-shortened 2023 campaign for the right-hander, as Bieber was limited to 128 innings while missing about two and a half months due to elbow inflammation.  He returned from the 60-day injured list to make two starts in late September, which seemingly indicated that the problem was behind him, and that Bieber could now look forward to a more normal offseason and ramp-up routine.  However, as the Guardians’ statement indicates, Bieber had some discomfort in his elbow following his first start this year, and the problem continued through his next outing.

Certainly nothing appeared to be amiss in terms of results, given that Bieber looked completely dominant in tossing 12 shutout innings and recording 20 strikeouts (against just one walk and 10 hits allowed) over his two starts.  This will now unfortunately mark the last we’ll see of Bieber on a big league mound for the next 13-15 months, and we might have already seen his final outing in a Cleveland uniform since he is a free agent this winter.

It counted as something of a surprise to see Bieber even still with the Guardians on Opening Day, given how it was widely assumed that the right-hander would be traded in advance of his walk year.  The Guards have routinely traded star players within 12-18 months of free agency since the organization is rarely (Jose Ramirez notwithstanding) willing to pay the money necessary to sign such prominent names to contract extensions.  As frustrating as this process has been for Cleveland fans, the front office’s track record in these trades has been pretty successful, and some of the players gained in those deals have helped the Guardians to remain competitive despite low payrolls.

If it wasn’t for his elbow issue last season, it is quite possible the Guards might’ve dealt Bieber at the last trade deadline.  His health status surely impacted his trade value this past winter, as despite reports linking the Angels, Dodgers, Reds, Yankees, and Cubs to Bieber’s market, Cleveland wasn’t able to work out a deal with any of these (and undoubtedly many other) interested suitors.  It’s easy to say now in the wake of Bieber’s Tommy John surgery that the Guardians should’ve moved him for whatever half-decent offer they received, though we don’t know what offers were on the table, and naturally the Guards weren’t keen on selling low on such a valuable trade asset.

There’s also the value of what Bieber brought to Cleveland’s own rotation, as the Guardians were hit with a lot of injuries to notable starters in 2023.  The team’s outstanding pitching development pipeline helped cover this problem in impressive fashion with the emergence of Gavin Williams, Tanner Bibee, and Logan Allen, and going into this season, the idea of that young trio teaming with Bieber and the returning Triston McKenzie seemed like a promising step in the Guards’ plans to return to contention.  However, Williams started the season on the 15-day IL due to elbow discomfort, and both Ben Lively and Xzavion Curry are also on the IL since a virus set the two pitchers back during Spring Training.

Veteran Carlos Carrasco has already stepped into the rotation in Williams’ place, and the Guardians will now have to hope for a quick recovery from either Lively or Curry with Bieber gone for the season.  Jaime Barria is also a candidate to pick up starts in the short term, or Hunter Gaddis or Tyler Beede could be stretched out from their current relief roles, or used in a piggyback/bulk starter capacity.

A fourth-round pick in the 2016 draft, Bieber became the latest star product of the Cleveland pitching factory when he made his MLB debut in 2018, and then finished fourth in AL Cy Young Award voting in 2019.  That breakout year led to Bieber winning the Cy during the shortened 2020 season, when he posted a 1.63 ERA over 77 1/3 innings.  While the season’s abbreviated nature carries an obvious asterisk, it was just the 13th time in MLB history that a pitcher led the entire league in ERA, wins (eight), and strikeouts (122) in the same year.

Bieber hasn’t since returned to those heights, though he still has a 3.13 ERA in 436 2/3 innings from 2021-24, and he was an All-Star in 2021 and a seventh-place finisher in Cy Young Award voting in 2022.  With this success came increasingly larger paydays throughout Bieber’s arbitration-eligible years, culminating in the arb-avoiding $13.125MM deal he signed for 2024.  A big bounce-back season would’ve therefore set him up quite nicely for a pricey free agent contract in the 2024-25 offseason, especially if he could’ve avoided a qualifying offer via a midseason trade from the Guardians.

As it stands now, Bieber might have to wait quite some time to score a hefty multi-year commitment.  Even if he pitches well after returning partway through the 2025 season, clubs might want to see a larger sample size of good health and good results before guaranteeing a nine-figure salary.  Assuming then that Bieber pitched well and stays healthy throughout 2026, he might then have a safer track record….but teams could then be wary of Bieber’s age, since 2027 would be his age-32 season.

Under the circumstances, there is a chance the Guardians could yet retain Bieber into 2025, as unlikely as this scenario would’ve seemed even a few days ago.  Cleveland might look to extend Bieber through the 2025 campaign or even both the 2025-26 seasons, on a low salary for 2025 and then the rest of the money backloaded into 2026.  We’ve seen such contractual models used for other pitchers recovering from lengthy injury rehabs, most recently Brandon Woodruff’s two-year, $17.5MM deal to re-sign with the Brewers less than two months ago.  If Bieber and the Guards had interest in such an arrangement, Bieber could complete his entire rehab in a familiar environment, and the Guardians could still get some benefit from having Bieber for part of 2025 and perhaps 2026.

Jonathan Loaisiga To Undergo Season-Ending UCL Surgery

By | at

Yankees reliever Jonathan Loaisiga revealed to reporters (including MLB.com’s Bryan Hoch) that he will need surgery to repair a torn UCL.  The procedure isn’t a Tommy John surgery so it comes with a shorter recovery timeline of 10-12 months, but Loaisiga will obviously still miss the rest of the 2024 season.

New York already placed Loaisiga on the 60-day injured list yesterday with what was described as a right flexor strain, and the fact that the right-hander was immediately sent to the 60-day IL was an ominous hint that he might be facing a particularly serious injury.  His 2024 campaign will now unfortunately come to an end after only three games and four scoreless innings.

This is the most serious injury yet in what has been a star-crossed career for the 29-year-old.  When Loaisiga has been able to pitch, he has been very effective — over 219 2/3 MLB innings, the righty has a 3.44 ERA, 22.5% strikeout rate, 7.8% walk rate, a very impressive 54.7% grounder rate, and some of the best soft-contact numbers of any hurler in the sport.  His bottom-line results have only better since a full-time move to relief pitching in 2021, and that season saw Loaisiga post a 2.17 ERA in 70 2/3 innings over 57 appearances.

2021 was also just about the healthiest season of Loaisiga’s career, and even that breakout campaign saw him miss about a month due to a rotator cuff strain and a stint on the COVID-related injury list.  He has since missed about seven weeks in 2022 with shoulder inflammation, and was then limited to 17 2/3 innings in 2023 due to elbow inflammation, surgery to remove a bone spur from that troublesome elbow, and then another inflammation-related IL placement last September.  This is all on top of a Tommy John surgery that Loaisiga did require back in 2016 soon after joining the Yankees organization.

Since Loaisiga is a free agent after the season, it is possible he has played his last game in the pinstripes.  The Yankees might simply want to move on from a pitcher with so many health-related question marks, yet Loaisiga won’t have a particularly high price tag coming off a lost season.  Since the Yankees know his injury history as well as anyone, if they still have faith Loaisiga can return, it seems entirely possible the two sides could agree on a low-cost one-year contract for 2025.  Given how the surgery hasn’t even taken place yet, there’s no rush for either side to make a decision yet, and New York will have several months to monitor Loaisiga’s recovery process.

From Loaisiga’s own perspective, obviously the UCL injury is a huge blow on many levels, but a good and healthy season would’ve lined him up for a nice free agent deal.  Though he lacks the big strikeout numbers that usually lead to the highest tier of reliever contracts, Loaisiga’s knack for inducing soft contact and keeping the ball on the ground would’ve drawn attention from plenty of suitors.  At a much lower price tag, this might still end up being the case in free agency, as Loaisiga has appeal as a buy-low candidate if he can establish that he’s healthy.

Scott Effross (back surgery) and Lou Trivino (Tommy John surgery) aren’t expected to be available until closer to midseason, plus the Yankees are being cautious with Tommy Kahnle’s recovery from shoulder inflammation since he was still battling some residual soreness in Spring Training.  Between these injured pitchers and Loaisiga, there is plenty of opportunity emerging in New York’s bullpen for the several new relievers acquired over the offseason.

Apart from the injury concerns in the relief corps, the larger-scale question of Gerrit Cole’s health is still hanging over the team as a whole, since the ace will be out until at least late May recovering from nerve inflammation.  The Yankees have done well in developing relief pitchers and finding hidden-gem bullpen options, so expect the team to continue pursuing lower-level acquisitions until some of their in-house names get healthy or until some bigger-name possibilities become available closer to the trade deadline.

Spencer Strider To Undergo MRI On Right Elbow

By | at

Braves ace Spencer Strider will go for an MRI on his right elbow on Saturday after complaining of discomfort on Friday night (per Justin Toscano of the Atlanta Journal-Constitution). The All-Star right-hander threw just four innings and 88 pitches in his second start of the season, giving up five earned runs while striking out four. As Mark Bowman of MLB.com noted, his 12 whiffs were tied for the “sixth-lowest total he has induced while throwing at least 80 pitches” in his MLB career. For comparison, Strider produced 18 whiffs and eight strikeouts on 90 pitches in his season debut. To make matters worse, his velocity was down on all four of his pitches. Although Strider didn’t mention his discomfort until he exited the game (per David O’Brien of The Athletic), something was clearly off throughout his start.

Despite his unimposing stature, Strider is one of the hardest-throwing starting pitchers in baseball. His four-seam fastball averaged 97.2 mph and topped out at 100.5 mph in 2023. He pairs his blistering fastball with a terrific slider, a changeup (against left-handed batters), and as of this year, a curveball. For a flame-throwing hurler toying with a new breaking pitch, the words “elbow discomfort” are especially worrisome. Not to mention, Strider has already suffered a torn UCL, undergoing Tommy John surgery in 2019 during his time at Clemson University.

Strider burst onto the scene in 2022 and established himself as one of the best pitchers in the game the following year. He led the National League in wins, strikeouts, and FIP, en route to All-MLB First Team honors. He entered the 2024 campaign as the undisputed ace of a strong Braves rotation and a popular preseason pick to win the NL Cy Young. A serious elbow injury would be devastating for both Strider and his club.

Even if the MRI comes back clean, Bowman suggests Atlanta will exercise caution with Strider over the next two weeks. He could take a 15-day trip to the IL while his elbow regains strength. After all, there is little harm in playing it safe.

The Braves remain the favorites in the NL East even if Strider misses significant time. Still, any injury to their No. 1 starter would be a huge blow, particularly if Strider is unavailable to pitch in the playoffs. The team provided little reason for optimism or pessimism after the game, so fans will have to wait until Saturday to learn more about the extent of Strider’s potential injury.

Trevor Story Exits With Left Shoulder Pain

By | at

Red Sox shortstop Trevor Story injured his shoulder on Friday as he dove to field a groundball. He hit the ground in significant distress and eventually left the game holding his arm. Shortly afterward, the team told reporters (including Christopher Smith of MassLive) that he exited with “left shoulder pain.” Presumably, the Red Sox will provide more details after the game, although Story might need further evaluation on Saturday before receiving a proper diagnosis.

Story has been something of an injury magnet throughout his career, spending time on the injured list in six of his first eight MLB seasons from 2016-23. He tore a thumb ligament in 2016, suffered a shoulder strain in 2017, sprained his thumb in 2019, dealt with elbow inflammation in 2021, and fractured his wrist (and suffered a heel contusion) in 2022. Most recently, he spent the first four months of the 2023 season recovering from an internal brace procedure to repair his UCL.

The Red Sox, who signed Story to a six-year, $140 million contract ahead of the 2022 campaign, were counting on him to be their regular shortstop this year. He struggled tremendously at the plate in 2023, slashing .203/.250/.316 in 43 games. However, he looked phenomenal at shortstop, producing 8 DRS and 8 OAA in just 314 defensive innings. Surely, the Red Sox were hoping that after a regular, healthy offseason, Story could get back on track at the plate. Over his first seven seasons, he produced an .849 OPS and 111 wRC+.

Instead, it seems as if Story is headed to the injured list early in 2024. Boston is low on infield depth with second baseman Vaughn Grissom already on the IL, but Pablo Reyes can cover at shortstop. Meanwhile, utility man Romy Gonzalez, currently at Triple-A, is a likely candidate to fill an empty spot on the bench.

Yankees Place Jonathan Loaisiga On 60-Day IL, Select Dennis Santana

By and | at

8:57am: Loaisiga first felt discomfort in his elbow near the end of his most recent outing on Wednesday, manager Aaron Boone explained to the Yankees beat this morning (X link via Greg Joyce of the New York Post). He called the injury “concerning,” noting that an MRI conducted last night revealed a “significant” strain. Loaisiga and the team are gathering more information on the injury and will determine next steps for the right-hander once they’ve received additional opinions.

7:35am: The Yankees have placed right-handed reliever Jonathan Loaisiga on the 60-day injured list with a right flexor strain, the team announced. In a corresponding move, the team has selected the contract of right-hander Dennis Santana. He’s joining the big league bullpen.

Loaisiga, 29, has all the makings of a high-end leverage reliever but hasn’t been able to stay healthy enough to establish himself in that role. He showed just how dominant he could be back in 2021 when he pitched 70 2/3 innings of 2.17 ERA ball with an above-average 24.4% strikeout rate, a very strong 5.4% walk rate and a sensational 60.6% ground-ball rate. The Nicaraguan-born righty averaged a blazing 98.4 mph on his sinker that season, notched an excellent 13.7% swinging-strike rate and posted a mammoth 41.1% opponents’ chase rate on pitches off the plate.

Unfortunately for both the Yankees and for Loaisiga, that’s the only season in which he’s ever thrown even 50 big league innings. Loaisiga has only reached even 20 appearances in two seasons. Since committing to a bullpen role in 2020, he’s delivered 163 1/3 innings with a 2.98 ERA (3.34 FIP, 3.42 SIERA), 20.3% strikeout rate, 6.5% walk rate and 58% grounder rate. There’s little doubting the raw talent is there to make him a star bullpen arm, but he’s missed time due to a shoulder strain, subsequent shoulder inflammation, elbow inflammation (twice) and now a flexor strain that’ll sideline him into at least the early summer months.

If Loaisiga’s absence extends further than that 60-day minimum, it’s feasible this could spell the end of his time in the Bronx entirely. The right-hander has five-plus years of major league service time and is slated to become a free agent at season’s end.

Santana, 27, signed a minor league pact with the Yankees back in early December. Like Loaisiga, he features a power sinker and strong ground-ball rates when at his best, but he hasn’t found nearly the same success and consistency that Loaisiga has when healthy.

Once one of the Dodgers’ top-ranked pitching prospects, Santana has bounced to the Rangers, Mets and now Yankees since leaving Los Angeles. He’s pitched just 149 2/3 innings in the big leagues and has a pedestrian 5.17 ERA to show for it (though a 4.26 FIP and 4.47 SIERA are a bit more favorable). Santana has averaged just under 96 mph on his sinker in his career and has kept the ball on the ground at a nearly 50% clip since adopting that as his primary offering. But he’s walked more than 12% of his big league opponents and struggled with men on base, resulting in a well below-average strand rate that’s helped to inflate his ERA.

Santana has regularly missed bats at a high level in the upper minors, and his power sinker fits a mold that the Yankees tend to prefer out of their late-inning relievers. He’ll need to improve his command, but Santana wouldn’t be the first relatively obscure arm to break out with the Yankees if he can get himself on track in the Bronx. He’s out of minor league options, however, so it could be a short stint on the 40-man roster if the Yankees feel they need to open another spot in the near future. If he gets a decent leash and can find some success, he’s controllable through the 2026 season via arbitration.

Athletics To Play 2025-27 Seasons In Sacramento Ahead Of Scheduled Move To Las Vegas

By | at

11:20am: Lindsey Adler of the Wall Street Journal reports that the A’s will not have a city associated with their name for the next three seasons. Rather than the “Sacramento Athletics,” they’ll just be referred to as the Athletics or the A’s, with no city designation.

11:05am: The Chronicle’s Eli M. Rosenberg reports that the City of Oakland’s final offer to the A’s was a three-year, $60MM lease of the Coliseum (X thread). That’s a notable step down from the previous $97MM price point but still apparently didn’t move the needle for Fisher and Athletics ownership.

10:12am: The 2024 season is officially the Athletics’ last year in Oakland. The team announced this morning that they’ll spend the 2025-27 seasons playing their home games in Sacramento’s Sutter Health Park ahead of their planned 2028 move to Las Vegas. There’s an option on the agreement for the A’s to spend a fourth year in Sacramento, presumably in the event that the construction of their new Las Vegas stadium is not completed on time.

Sutter Health Park is home to the Sacramento River Cats — the Giants’ Triple-A affiliate. It seems the two teams will share the stadium for at least the next three seasons — or at least that such an arrangement is under consideration. The press release announcing the Sacramento decision states: “Not only will fans be able to experience Major League Baseball in West Sacramento, but they will also still get to enjoy the beloved tradition of Minor League Baseball and the Sacramento River Cats.”

However, that’s not necessarily set in stone. John Shea, Susan Slusser and Steve Kroner of the San Francisco Chronicle report that the A’s and River Cats sharing Sutter Health Park is “one option.” The Chronicle trio further reports that there’s also been some consideration that the River Cats could play home games across multiple sites, including the Coliseum and the Giants’ Oracle Park.

River Cats president Chip Maxon told KCRA 3’s Michelle Dapper last week: “We are Sacramento’s team, we’re not going anywhere. If someone else were to play here, we’ve made it clear we want to play all 75 home games for the River Cats for the foreseeable future.”

Maxon’s comments notwithstanding, the NBA’s Sacramento Kings are the majority owner of the River Cats. Kings president and CEO Vivek Ranadivé issued the following statement:

“I’m thrilled to welcome the A’s to Sutter Health Park, where players and fans alike can enjoy a world-class baseball experience and create other unforgettable memories. Today marks the next chapter of professional sports in Sacramento. The passion of our fans is second to none, and this is an incredible opportunity to showcase one of the most dynamic and vibrant markets in the country.”

Said A’s owner John Fisher:

“We look forward to making Sutter Health Park our home through our move to Las Vegas. We extend our appreciation to the Kings and the City of West Sacramento for hosting the A’s while we work to complete our new ballpark in Las Vegas.”

There are, as one would expect, some logistical hurdles that need to be cleared. Sutter Health Park’s capacity is just over 14,000; it’s well smaller than the size of a standard big league stadium. While that invites plenty of jokes about the Athletics’ attendance, concerns regarding the size of the stadium extend beyond its sheer seating capacity. A’s players voiced concerns to the Chronicle about the size of the clubhouse and training room, the standards of the batting cages, and the lights at a Triple-A stadium. Right-hander Paul Blackburn also noted the location of the clubhouses, which are beyond the outfield wall as opposed to the MLB standard of being connected to the dugouts, as another issue.

On top of the facility itself, the A’s will need to sort through television broadcast specifics with NBC Sports California. Shea, Slusser and Kroner report that the A’s made $67MM from their television contract last year but will likely revise that deal and receive less revenue now. However, the move to Sacramento allows the A’s to avoid the City of Oakland’s proposed $97MM fee for the extension of the current Coliseum lease. It also allows Fisher to retain a 50% stake in the Coliseum property itself.

Suffice it to say, there are ample hurdles yet to be cleared and plenty of unknowns to be determined. As The Athletic’s Melissa Lockard points out, the fact that the A’s are endeavoring to play their home games in West Sacramento — rather than at their own Triple-A stadium in Las Vegas — speaks to the difficulties of making an arrangement like this work for all parties involved. That the A’s are even announcing this despite ostensibly not having a concrete plan outlined for where the River Cats will play only adds to the disjointed and disorganized feeling that has been emblematic of their entire relocation saga.

White Sox Re-Sign Mike Clevinger

By | at

April 4: The White Sox have formally announced Clevinger’s new contract and confirmed the $3MM base salary. The team also confirmed the previously reported DFA of infielder Jose Rodriguez, which opens a spot on the 40-man roster. Clevinger has agreed to be optioned to the team’s Arizona Complex League affiliate to build up.

April 1, 9:50pm: Clevinger’s deal with the White Sox will pay him $3MM in 2024, with an additional $3MM available in incentives (per Robert Murray of FanSided).

4:55pm: The White Sox and right-hander Mike Clevinger are in agreement on a deal, pending a physical, reports Robert Murray of FanSided. The full details of the pact for the ACES client are not yet known, though Jon Heyman of The New York Post relays that it’s a one-year deal.

Clevinger, 33, was one of many free agents to linger on the open market for a very long time, as the offseason turned out to be far slower than anyone had anticipated. He had signed with the White Sox last winter, a one-year deal with a $12MM guarantee. It was later reported that Clevinger was under investigation for domestic violence allegations, though that investigation concluded without the pitcher receiving any discipline.

He went on to have a decent season for the Sox, throwing 131 1/3 innings with a 3.77 earned run average. He went on the injured list twice, the first due to right wrist inflammation and the second due to right biceps inflammation, but still managed to take the ball 24 times.

Though the ERA was nice, there were other numbers that were less impressive. His 20% strikeout rate was below league average and well below the 28% rate Clevinger posted from 2017 to 2020. He underwent Tommy John surgery in November of 2020, missing the entire 2021 season, and hasn’t been quite the same since his return. His velo hasn’t quite come all the way back to pre-surgery levels and he only struck out 18.8% of batters faced in 2022.

In 2023, luck may have helped him keep his ERA low, as his .281 batting average on balls in play and 77.2% strand rate were both on the fortunate side. His 4.28 FIP and 4.81 SIERA suggest he may not have been as effective as the ERA make him look.

Perhaps it was those underlying metrics or maybe it was just a side effect of the generally weak offseason, but Clevinger didn’t find a deal to his liking during the winter and will now be signing after the 2024 campaign has already begun.

The Sox don’t need Clevinger to be an ace, as simply having him eat some innings should be useful to them. They traded away Lucas Giolito and Lance Lynn last year as they kicked off a rebuild, then flipped Dylan Cease this winter and moved Michael Kopech into a relief role. Touki Toussaint was outrighted off the roster and Jesse Scholtens required Tommy John surgery. With José Ureña having signed with the Rangers, the Sox came into the 2024 season with every pitcher that made more than three starts for them in 2023 either gone, injured or in the bullpen, prior to Clevinger’s return.

The rotation currently consists of new arrivals. Reliever Garrett Crochet is going in the opposite direction of Kopech, while Michael Soroka was acquired in a trade and Erick Fedde and Chris Flexen were signed as free agents. The club also brought in Jared Shuster, Jake Eder and Jairo Iriarte via trades in the past year, but each has been optioned for work in Triple-A.

That leaves one spot open, which Clevinger will fill at some point. Since he missed all of Spring Training, he will presumably need a bit of tune-up time to get into game shape, even if he’s been building up a pitch count in some unofficial capacity.

Any of their current starters could find themselves available at the trade deadline, which could further open up the need for innings. Soroka and Flexen are both impending free agents while Fedde is controlled through 2025 and Crochet through 2026. With the club’s timeline for a return to contention unclear, there would be an argument for making any of those guys available.

If those players end up getting moved, some of the aforementioned younger pitchers could get an audition but the likelihood of needing someone to take the ball is high, with injuries sure to crop up throughout the year. If Clevinger can find a way to get his strikeouts back, he could pitch himself into a trade scenario as well.

Show all

MLB Trade Rumors is not affiliated with Major League Baseball, MLB or MLB.com

Do not Sell or Share My Personal Information

hide arrows scroll to top